Home  ›  Switzerland  ›  Kuros Biosciences LTD

Kuros Biosciences LTD insider transactions

Healthcare · SIX · Switzerland
Net insider signal · last quarter
Selling
Share price & insider trades · last quarter▲ buy   ▼ sell
CHF 27.7CHF 17.010 Apr09 Jul

Insiders were sellers over the last quarter — 1 sale, no buys — a net CHF 139K of selling. Most recent filing: 26 May 2026.

Net insider flow · last quarter
-CHF 139K0 buys · 1 sells
Insider profiles
＋●.●% avg 3m · win rate
🔒  Subscribe to access

Transactions

DateInsiderRoleTypeValue
26 May 2026ManagementSellCHF 139,385
16 Mar 2026ManagementBuyCHF 65,224
12 Dec 2025ManagementSellCHF 906,000
Discover the latest filings, live alerts, top insiders and industry rankings →
05 Dec 2025Management▼ SellCHF 933,300
13 Nov 2025Management▲ BuyCHF 54,440
22 Oct 2025Management▼ SellCHF 113,114
20 Oct 2025Management▼ SellCHF 2,635,000
20 Oct 2025Management▼ SellCHF 1,603,100
20 Oct 2025Management▼ SellCHF 1,550,000
17 Oct 2025Management▼ SellCHF 202,744
17 Oct 2025Management▼ SellCHF 151,032
21 Aug 2025Management▼ SellCHF 37,246
18 Aug 2025Management▼ SellCHF 4,716,676
18 Aug 2025Management▼ SellCHF 2,355,975
15 Aug 2025Management▲ BuyCHF 412,200
07 Jul 2025Management▼ SellCHF 580,000
03 Jul 2025Management▲ BuyCHF 275,000
17 Jun 2025Management▲ BuyCHF 50,560
03 Jun 2025Management▼ SellCHF 38,693
28 May 2025Management▼ SellCHF 181,860
23 Apr 2025Management▼ SellCHF 1,264,800
24 Mar 2025Management▲ BuyCHF 55,500
18 Mar 2025Management▲ BuyCHF 38,200
Showing older filings · the 3 most recent are subscriber-only
Visit the website →

Under the EU Market Abuse Regulation (MAR), executives and board members (PDMRs) at Swiss-listed companies must disclose dealings in their company's shares to SIX. Insider Transaction Terminal aggregates these filings daily, filters out the noise and gives you the trades that actually matter.